|
Insider Trading: Dexcom Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. Table 2 shows the detailed insider transactions of Dexcom Inc since 2005.
The reporting company's ticker symbol is DXCM.
The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $1,937,273.
The total value of stock sales is $123,058,149.
The total value of stock exercises is $155,369.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Dexcom Inc (DXCM) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Dexcom Inc (DXCM) in the past 24 months. See table 2 for insider transaction details.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Dexcom Inc (DXCM).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-11 | 47,500 | 91,850 | 0 | 0 | 0 | 0 |
| 2008-08 | 10,000 | 66,700 | 0 | 0 | 0 | 0 |
| 2008-03 | 247,000 | 1,205,633 | 0 | 0 | 0 | 0 |
| 2007-08 | 0 | 0 | 3,296 | 23,401 | 0 | 0 |
| 2007-03 | 0 | 0 | 4,000 | 28,700 | 0 | 0 |
| 2006-12 | 0 | 0 | 17,363 | 203,164 | 0 | 0 |
| 2006-07 | 3,000 | 33,600 | 0 | 0 | 0 | 0 |
| 2006-06 | 0 | 0 | 0 | 0 | 53,125 | 21,250 |
| 2006-05 | 0 | 0 | 3,482,500 | 83,580,000 | 172,500 | 56,500 |
| 2006-03 | 0 | 0 | 40,648 | 748,435 | 46,614 | 23,307 |
| 2006-02 | 0 | 0 | 0 | 0 | 14,375 | 4,312 |
| 2006-01 | 0 | 0 | 0 | 0 | 100,000 | 50,000 |
| 2005-12 | 0 | 0 | 4,000 | 58,348 | 0 | 0 |
| 2005-11 | 0 | 0 | 2,333,900 | 31,053,551 | 0 | 0 |
| 2005-10 | 0 | 0 | 611,000 | 7,362,550 | 0 | 0 |
| 2005-08 | 9,950 | 101,490 | 0 | 0 | 0 | 0 |
| 2005-04 | 36,500 | 438,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Dexcom Inc (DXCM)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-19 | Pacelli Steven Robert (SVP, Corporate Affairs) | Purchase | 5,000 | 2.00 | 10,000 |
| 2008-11-19 | Valdes Jorge A (SVP of Operations) | Purchase | 2,500 | 1.90 | 4,750 |
| 2008-11-19 | Gregg Terrance H (President and CEO) | Purchase | 40,000 | 1.93 | 77,100 |
| 2008-08-08 | Gregg Terrance H (President & CEO) | Purchase | 10,000 | 6.67 | 66,700 |
| 2008-03-14 | Valdes Jorge A (SVP of Operations) | Purchase | 2,000 | 4.87 | 9,739 |
| 2008-03-14 | Gregg Terrance H (President and CEO) | Purchase | 60,000 | 4.87 | 292,224 |
| 2008-03-14 | Skyler Jay S (Director) | Purchase | 20,000 | 4.97 | 99,400 |
| 2008-03-14 | Nelson Glen D (Director) | Purchase | 100,000 | 4.86 | 486,250 |
| 2008-03-14 | Lucas Donald L (Director) | Purchase | 35,000 | 4.91 | 171,908 |
| 2007-08-02 | Lucas Donald A (Director) | Sale | 3,296 | 7.10 | 23,401 |
| 2007-03-15 | Lucas Donald A (Director) | Sale | 4,000 | 7.18 | 28,700 |
| 2006-12-04 | Lucas Donald A (Director) | Sale | 17,363 | 11.70 | 203,164 |
| 2006-07-26 | Valdes Jorge A (Vice President of Engineering) | Purchase | 3,000 | 11.20 | 33,600 |
| 2006-06-21 | Brauker James H (VP, Research & Development) | Option Exercise | 53,125 | .40 | 21,250 |
| 2006-05-02 | Kemper Steven J (Chief Financial Officer) | Sale | 75,000 | 24.00 | 1,800,000 |
| 2006-05-02 | Brauker James H (VP Research & Development) | Sale | 82,500 | 24.00 | 1,980,000 |
| 2006-05-02 | Rasdal Andrew P (President & CEO) | Sale | 125,000 | 24.00 | 3,000,000 |
| 2006-05-02 | Rasdal Andrew P (President & CEO) | Option Exercise | 125,000 | .30 | 37,500 |
| 2006-05-02 | Brister Mark (VP Advanced Development Teams) | Sale | 50,000 | 24.00 | 1,200,000 |
| 2006-05-02 | Balo Andrew K (VP of Clinical & Regulatory) | Sale | 100,000 | 24.00 | 2,400,000 |
| 2006-05-02 | Balo Andrew K (VP of Clinical & Regulatory) | Option Exercise | 47,500 | .40 | 19,000 |
| 2006-05-02 | Split Rock Partners Llc (10% Owner) | Sale | 2,200,000 | 24.00 | 52,800,000 |
| 2006-05-02 | Carney Sean (Director) | Sale | 400,000 | 24.00 | 9,600,000 |
| 2006-05-02 | Lucas Donald L (Director) | Sale | 50,000 | 24.00 | 1,200,000 |
| 2006-05-02 | Warburg Pincus Llc (10% Owner) | Sale | 400,000 | 24.00 | 9,600,000 |
| 2006-03-13 | Blickenstaff Kim D (Director) | Sale | 10,000 | 18.55 | 185,513 |
| 2006-03-10 | Blickenstaff Kim D (Director) | Sale | 10,648 | 18.48 | 196,775 |
| 2006-03-09 | Blickenstaff Kim D (Director) | Sale | 20,000 | 18.31 | 366,147 |
| 2006-03-07 | Nelson Glen D (Director) | Option Exercise | 46,614 | .50 | 23,307 |
| 2006-02-01 | Brauker James H (VP, Research & Devel) | Option Exercise | 14,375 | .30 | 4,312 |
| 2006-01-05 | Kemper Steven J (Chief Financial Officer) | Option Exercise | 25,000 | .50 | 12,500 |
| 2006-01-04 | Lucas Donald L (Director) | Option Exercise | 75,000 | .50 | 37,500 |
| 2005-12-12 | Blickenstaff Kim D (Chairman) | Sale | 4,000 | 14.59 | 58,348 |
| 2005-11-29 | Blickenstaff Kim D (Chairman) | Sale | 8,000 | 14.59 | 116,744 |
| 2005-11-28 | Blickenstaff Kim D (Chairman) | Sale | 1,900 | 14.53 | 27,607 |
| 2005-11-10 | Waubeeka Llc (10% Owner) | Sale | 1,053,000 | 13.30 | 14,004,900 |
| 2005-11-10 | Russo Guy M (10% Owner) | Sale | 1,053,000 | 13.30 | 14,004,900 |
| 2005-11-01 | Split Rock Partners Llc (10% Owner) | Sale | 218,000 | 13.30 | 2,899,400 |
| 2005-10-25 | Split Rock Partners Llc (10% Owner) | Sale | 611,000 | 12.05 | 7,362,550 |
| 2005-08-12 | Skyler Jay S (Director) | Purchase | 9,950 | 10.20 | 101,490 |
| 2005-04-13 | Lucas Donald A (Director) | Purchase | 6,500 | 12.00 | 78,000 |
| 2005-04-13 | Skyler Jay S (Director) | Purchase | 30,000 | 12.00 | 360,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Dexcom Inc (symbol DXCM,
CIK number 1093557) see
the Securities and Exchange Commission (SEC) website.
|
|
